Stay updated on Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Sign up to get notified when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.

Latest updates to the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page
- Check7 days agoChange DetectedAdded Revision: v3.5.2. Deleted Revision: v3.5.0.SummaryDifference0.0%

- Check14 days agoNo Change Detected
- Check21 days agoNo Change Detected
- Check29 days agoChange DetectedAdded a related topic MedlinePlus Genetics and a new reference to the Lancet Oncology paper with revision v3.5.0; the prior Erratum entry for that paper (v3.4.3) was removed.SummaryDifference0.2%

- Check43 days agoChange DetectedExpanded indexing terms and metadata have been added to the page, including MeSH terms and record history details.SummaryDifference84%

- Check50 days agoChange DetectedRevision: v3.4.3 was added to the page. No substantive study details or eligibility criteria appear to have changed.SummaryDifference21%

- Check57 days agoChange DetectedThe page now lists 'Multiple myeloma' as a disease/topic and adds MedlinePlus Genetics as a related topic, which enhances context and navigation without altering the study details.SummaryDifference0.1%

- Check64 days agoChange DetectedA Lancet Oncology article on carfilzomib dosing (A.R.R.O.W.) was added to the Publications section with new update dates and was subsequently removed.SummaryDifference0.3%

Stay in the know with updates to Carfilzomib, Iberdomide, Dexamethasone Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Carfilzomib, Iberdomide, Dexamethasone Clinical Trial page.